Efficacy of basiliximab induction in poorly matched living donor renal transplantation

Non-depleting antibody induction has the best safety profile in transplant recipients without an increased risk of infection or malignancy. This observational study was performed in intermediate immunologic risk live donor renal transplants to assess basiliximab efficacy in patients on tacrolimus, m...

Descripción completa

Detalles Bibliográficos
Autores principales: Gundlapalli, S., Rathi, M., Kohli, H. S., Jha, V., Sharma, A., Minz, M., Sakhuja, V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3841506/
https://www.ncbi.nlm.nih.gov/pubmed/24339516
http://dx.doi.org/10.4103/0971-4065.120332

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3841506/
https://www.ncbi.nlm.nih.gov/pubmed/24339516
http://dx.doi.org/10.4103/0971-4065.120332

Ejemplares similares